Progesterone Dosing in PCOS: Sequential, Not Daily
For women with PCOS on sequential estrogen-progesterone therapy, progesterone is taken cyclically for 12-14 days per 28-day cycle, NOT daily. This sequential approach provides endometrial protection while allowing withdrawal bleeding and maintaining cycle regularity.
Sequential Regimen Specifics
The standard protocol involves:
- Estrogen: Administered continuously throughout the 28-day cycle
- Progesterone: Added for only 12-14 consecutive days per cycle (typically days 14-27)
- Typical dose: 200-300 mg oral micronized progesterone (MP) at bedtime during the progestogen phase 1
The FDA-approved dosing for endometrial protection in women taking estrogens is 200 mg progesterone at bedtime for 12 continuous days per 28-day cycle 2. This sequential approach has been validated in clinical trials showing only 6% hyperplasia rates compared to 64% with estrogen alone 2.
Why Sequential Rather Than Continuous?
Sequential therapy is preferred in PCOS for several key reasons:
- Endometrial protection: The 12-14 day progestogen exposure provides complete secretory transformation of the endometrium, preventing hyperplasia 1
- Withdrawal bleeding: Allows regular, predictable menstrual cycles—important for monitoring and early pregnancy detection in PCOS women who may spontaneously ovulate 1
- Cardiovascular safety: Micronized progesterone (MP) in cyclic administration shows lower cardiovascular and thrombotic risk compared to synthetic progestins 1
Alternative: Continuous Combined Therapy
Continuous daily progesterone is an option only if avoiding withdrawal bleeding is specifically desired 1. This requires:
- Lower daily doses: 5 mg dydrogesterone, 2.5 mg medroxyprogesterone acetate (MPA), or 1 mg norethisterone daily 1
- Continuous administration: Both estrogen and progestogen taken every day without breaks
- Trade-off: No withdrawal bleeding, but loses the pregnancy detection advantage of sequential therapy 1
Progestogen Selection Hierarchy
First choice: Micronized progesterone (MP) 1
- 200 mg orally or vaginally for 12-14 days per cycle
- Superior safety profile for cardiovascular and thrombotic risk
- Neutral effect on blood pressure
Second choices (if MP contraindicated/not tolerated):
Avoid progestins with anti-androgenic effects in PCOS patients with signs of hypoandrogenism or sexual dysfunction 1.
Common Pitfalls to Avoid
- Don't prescribe daily progesterone when sequential is intended: This is the most common error—sequential means 12-14 days only, not continuous
- Don't use continuous regimens without patient preference discussion: Sequential allows withdrawal bleeding which helps detect spontaneous pregnancy in PCOS 1
- Don't underdose: 200 mg MP is the validated dose for endometrial protection; lower doses may be insufficient 1, 2
- Timing matters: Progesterone should be taken at bedtime due to sedative effects and potential dizziness 2
Clinical Context for PCOS
Women with PCOS have chronic anovulation and unopposed estrogen exposure, creating significant endometrial cancer risk. The sequential progestogen phase induces secretory transformation and withdrawal bleeding, mimicking a normal menstrual cycle while providing essential endometrial protection 3, 4. This approach addresses both the menstrual irregularity and hyperplasia risk inherent to PCOS.
Recent evidence suggests cyclic progesterone may also improve other PCOS symptoms including fluid retention and breast tenderness through neuroendocrine effects 5, though this requires further validation.